Skip to main content
Clinical Trials/NCT03654209
NCT03654209
Completed
Not Applicable

Prospective Randomized Controlled Trial Describing the Recurrence Rate of Adenomas in Sessile or Flat Colonic Lesions 15mm or Larger Receiving Post-resection Site Treatment With Snare Tip Soft Coagulation or Argon Plasma Coagulation

Indiana University10 sites in 1 country384 target enrollmentOctober 16, 2018
ConditionsRecurrence

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Recurrence
Sponsor
Indiana University
Enrollment
384
Locations
10
Primary Endpoint
Types of Recurrences
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Patients who have provided informed consented and are scheduled to undergo endoscopic mucosal resection (EMR) of lesions 15mm and larger will be randomized to STSC (80 W, Effect 5) vs APC (preferred settings) vs No Treatment of the perimeter of the EMR site.

Detailed Description

Data regarding polyp morphology, location \& shape will be recorded in addition to procedure and treatment length. Injection fluid use and clipping will also be recorded in addition to any procedural complications. All randomized subjects will receive a 30-day post procedure follow-up phone call and be scheduled, as per the standard of care, to receive a standard follow-up colonoscopy procedure after the initial procedure. The investigators will measure the rate of recurrence by endoscopic visualization of the EMR site at the first follow-up using endoscopic magnification and electronic chromoendoscopy, as well as systematic biopsy of the scars.

Registry
clinicaltrials.gov
Start Date
October 16, 2018
End Date
December 14, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Douglas K. Rex

Principal Investigator

Indiana University

Eligibility Criteria

Inclusion Criteria

  • 25 years and older
  • Ability to provide informed consent
  • Undergoing colonoscopy for screening, surveillance, diagnostic reasons, or removal of a lesion

Exclusion Criteria

  • Pedunculated lesions
  • Inflammatory bowel disease
  • Inability to provide informed consent
  • Lesions less than 15mm in largest dimension

Outcomes

Primary Outcomes

Types of Recurrences

Time Frame: 1 day

Description of whether recurrence was visible during the follow-up procedure and confirmed by pathology, visible during the follow-up procedure but not confirmed by pathology, or not visible during the follow-up procedure but confirmed by pathology of biopsies taken.

Recurrence

Time Frame: 1 day

The recurrence rate of adenomas at the site of any qualifying, previously resected lesions will be measured at the first follow-up colonoscopy

Secondary Outcomes

  • Time(1 day)
  • Complications(1 day)

Study Sites (10)

Loading locations...

Similar Trials